期刊文献+

维生素D_3对自发性高血压大鼠肾素-血管紧张素-醛固酮系统的影响 被引量:10

Influence of vitamin D_3 on renin-angiotensin-aldosterone system in the spontaneous hypertensive rats
原文传递
导出
摘要 目的观察维生素D3对自发性高血压大鼠血压及肾素-血管紧张素-醛固酮系统的影响。方法自发性高血压大鼠20只分为2组各10只,实验组给予维生素D3注射液3μg/(kg.d)溶于100μL丙二醇中腹腔注射,连续注射7d;对照组给予单纯丙二醇100μL腹腔注射7d。药物干预完成后观察2组大鼠血压变化。分别于1,3周后分批处死大鼠,收集血清和组织标本。ELISA法检测血清中25(OH)D3、血钙、甲状旁腺激素、肾素、血管紧张素Ⅱ和醛固酮水平。结果药物干预结束后1周,实验组大鼠收缩压较对照组低14mm Hg(P<0.01),25(OH)D3(156.00±28.50ng/mL)、血钙水平(59.00±7.67ng/mL)均高于对照组((2.28±0.17)mmol/L)和((2.06±0.12)mmol/L)(P<0.05),肾素、血管紧张素Ⅱ、甲状旁腺激素水平均低于对照组(P<0.05);3周后2组大鼠血压和上述指标比较差异均无统计学意义(P>0.05)。结论维生素D3可抑制肾素的合成和分泌,抑制肾素-血管紧张素-醛固酮系统,从而降低血压。 Objective To observe the influence of vitamin Ds on blood pressure and renin-angiotensin-aldosterone system (RAAS) in spontaneous hypertensive rats. Methods Twenty spontaneous hypertensive rats were randomly divided into two groups, with 10 rats in each group. The experimental group was intraperitoneally injected 3 μg/(kg· d) vitamin D3 for totally 7 days, which was dissolved in 100 μL propylene glycol. Control group was only injected 100μL propylene glycol for 7 days. Blood pressure was continuously observed after drug intervention. All rats were sacrificed one week or three weeks later respectively. Serum and organization samples were collected. Serum 25(OH) I)3 , calcium, parathyroid hormone, renin, angiotensin II and aldosterone concentration were detected with ELISA technique. Results The blood pressure of the experimental group was 14 mm Fig lower than that in control group one week later (P〈0.01). The 25 (OH)D3 level and calcium concentration were higher in experimental group ((156.00 + 28. 50) ng/mL and (59.00 ± 7.67) ng/mL) than those in control group ((2.28+0.17) mmol/L and (2.06+0. 12) retool/L) (P〈0.05). Renin, angiotensin H and parathyroid hormone concentration were lower in experimental group than those in control group (P〈 0.05). Three weeks later there were no significant differences in the all above indexes between two groups (P〉0.05). Conclusion Vitamin D3 can inhibit the synthesis and secretion of renin, inhibit the RAAS system and lower blood pressure.
出处 《中华实用诊断与治疗杂志》 2013年第3期228-230,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 国家自然科学基金(81160038)
关键词 高血压 维生素D3 大鼠 肾素-血管紧张素-醛固酮系统 Hypertension vitamin D3 rat renin-angiotensin-aldosterone system
  • 相关文献

参考文献13

  • 1Scott B B, McGeehan G M, Harrison R K. Development of inhibitors of the aspartyl protease renin for the treatment of hypertension[J].Curr Protein Pept Sci,2006,7(3) :241- 254.
  • 2符春晖,严华,陆永光,陈湘桂,黄军章.原发性高血压病患者肾素-血管紧张素-醛固酮系统活性的影响因素[J].中华实用诊断与治疗杂志,2011,25(7):633-635. 被引量:22
  • 3Li Y C, Qiao G, Uskokovic M, et al. Vitamin D; a negative endocrine regulator of the renin-angiotensin system and blood pressure[J]. J Steroid Biochem Mol Biol, 2004, 89/90 (1/5) : 387- 392.
  • 4Kong J, Kim G H, Wei M, etal. Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats[J]. AmJ Pathol,2010,177(2):622-631.
  • 5Anagnostis P, Athyros V G, Adamidou F, etal. Vitamin D andcardiovascular disease= a novel agent for reducing cardiovascular risk[J]. Curr Vasc Pharmacol,2010,8(5):720-730.
  • 6鞠云枫,杨留才.1,25-(OH)_2D_3在调节RAS中的作用研究[J].中国医药导报,2009,6(36):21-22. 被引量:4
  • 7Freundlich M, Quiroz Y, Zhang Z, et al. Suppression of renin angiotensin gene expression in the kidney by paricalcitol[J]. Kidney Int,2008,74(11) :1394-1402.
  • 8Sugden J A, Davies J I, Witham M D, et al. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levelsl[J]. Diabet Med, 2008,25 (3) 320- 325.
  • 9刘奕婷,蔡云飞,时景璞.25羟维生素D与高血压关系的荟萃分析[J].中华医学杂志,2012,92(18):1268-1271. 被引量:37
  • 10陈丽萌,陈晨.活性维生素D调节肾素分泌机制及其潜在降压作用的研究进展[J].北京医学,2010,32(4):283-285. 被引量:3

二级参考文献101

  • 1黄慧敏,张红,李惠翔,姜国忠,高冬玲,王秀利.表达E2F1小干扰RNA的逆转录病毒载体的构建[J].实用诊断与治疗杂志,2005,19(3):177-179. 被引量:5
  • 2杨海芸,曹国良.不同剂量辛伐他汀对高血压病患者血管活性物质水平的影响[J].实用诊断与治疗杂志,2007,21(1):20-22. 被引量:18
  • 3Bedyak N, Ayus JC, Achinger S, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt- sensitive animals [J]. Proc Natl Acad Sci,2007,104(43):16810--16815.
  • 4Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system [J]. J Clin Invest, 2002, 110(2):229-238.
  • 5Li YC, Qiao G, Uskokovic M, et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure [J]. J Steroid Biochem Mol Biol,2004,89(1-5):387-392.
  • 6Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems [J]. Am J Physiot Endocrinol Metab,2005,288(1):E 125-132.
  • 7Burgess ED, Hawkins RG, Watanabe M. Interaction of 125-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension [J]. Am J Hypertens,1990,3(12 Pt):903-905.
  • 8Resnick LM, Muller FB, Laragh JH. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism [J]. Ann Intern Med,1986,105(5):649-654.
  • 9Scragg R, Sewers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey [J]. Am J Hypertens,2007,20(7):713-719.
  • 10Lind L, Wengle B, Wide L, et al. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebocontrolled study [J]. Am J Hypertens,1989,2(1):20-25.

共引文献69

同被引文献84

  • 1中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会,杨杰孚,张健,韩雅玲.中国心力衰竭诊断和治疗指南2018[J].中华心力衰竭和心肌病杂志(中英文),2018,2(4):196-225. 被引量:785
  • 2牟建军.盐与高血压研究进展[J].中国医学前沿杂志(电子版),2011,3(2):22-25. 被引量:21
  • 3徐新娟,汪师贞.新疆地区高血压流行病学调查研究回顾[J].新疆医科大学学报,2004,27(3):312-314. 被引量:56
  • 4De Fraissinette B, Garcier J U, Dieu V, et al. Percutaneous transluminal angioplasty of dysplastic stenoses of the renal artery: results on 70 adults[J]. Cardiovasc Intervent Radiol, 2003,26(1) :46-51.
  • 5Slovut D P, Olin J W. Fibromuscular dysplasia[J]. N Engl J Med, 2004,350(18) : 1862-1871.
  • 6Rundback J H, Sacks D, Kent K C, et al. Guidelines for the reporting of renal artery revascularization in clinical trials[J]. Circulation,2002,106(12) : 1572- 1585.
  • 7Higashi Y, Sasaki S, Nakagawa K, et al. Endothelial function and oxidative stress in renovaseular hypertension[J]. N Engl J Med,2002,346(25) :1954-1962.
  • 8Vuong P N, Desooutter P, Mickley V, et al. Fibromuscular dysplasia of the renal artery responsible for renovascular hypertension: a histological presentation based on a series of 102 patients[J]. Vasa,2004,33(1) :13-18.
  • 9Tanaka R, Higashi M, Naito H. Angioplasty for non- arteriosclerotic renal artery stenosis: the efficacy of cutting balloon angioplasty versus conventional angioplasty [ J ]. Cardiovasc Intcrvent Radiol, 2007,30 (4) : 601-606.
  • 10Lovaria A, Nicolini A, Meregaglia D, et al. Interventional radiology in the treatment of renal artery stenosis[J]. Ann Urol, 1999,33(3) : 146-155.

引证文献10

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部